Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly, another thing that shows the strength of CYDY is it's a penny stock sitting at $3.14. There's only one reason a penny stocks goes that high, it's the real deal.
Gonna be some exciting days coming up very soon. And also another variable that could very well happen is OWS getting involved and buying millions more vials as fast as production can keep up.
CYDY 30 billion dollar market cap next year, 589 million O/S, do the math. That's a ten bagger at least. It could all start as early as next week.
And that's only the beginning
Ha! He's doing to NP what NP is doing to the FDA with Philippines
That would be an extreme positive!
IncellDx to launch Leronlimab Receptor Occupancy Assay reagents that use fluorescently labeled Leronlimab to aid labs trying to develop RO for leronlimab! Can be used under CLIA for HIV, cancer, COVID #incelldx #CCR5 @Cytodyn #leronlimab
— Bruce K. Patterson MD (@brucep13) December 11, 2020
Monday morning 4am PR complete enrollment in CD12
I think it will go higher. After approval for covid I believe more revenue will come from using off label for other ARDs.
Looking for a Monday morning PR on full CD12 enrollment. Who knows, at the rate enrollment is snowballing we might see the PR today.
ONLY SIX SPECIFIC MEDICATIONS LERONLIMAB LISTED FIRST
"The procedure codes introduce six specific medications that can be used for treatment of COVID-19. The drugs are leronlimab"
https://www.icd10monitor.com/cms-releases-new-icd-10-pcs-codes-for-covid-19
No necessarily, I took it as more of a so far so good, after all the patients have only been in the trial for about 6 months. And it all depends on the condition of the patient, was their cancer progressing at the time they started Leronlimab and now it's stable or even the tumors are gone. If that's the case it could very well lead to long term.
I'd say the the rapid increase in CD12 enrollment is related to doctors encouraging their patients to enroll after seeing positive results. Ever since BB jump-started the hospitals enrollment really took off and snowballed. First it raised to about 15 a week which was a really good number now it's almost twice that. For me this combined with the medicare code points to approval. Looking for a Monday morning 4am PR with full enrollment. Don't blink
Yes, but a lot of share holders are not day trading this stock and could care less. They are patiently waiting for the process to play out. With those share holders nothing has changed with their investment.
Wow!!! This screams OWS, it wouldn't surprise me if OWS set this up as to avoid any delay after approval.
You just won best post of the year!
Did you notice they will make hundreds of millions per month from Vyrologix?
CYDY is up 40% in two weeks. And with waiting for Covid approval till next year now priced in your price target is not looking good.
CytoDyn is looking into HIV cure within subset of patients,I can't remember exactly but I believe it's HIV patients with a blood cancer?
The Doctors and nurses that are giving the shots see everything. They see a patient recover rapidly after getting a shot from a trial it's only obvious the shot worked. Ultimately it's up to the patient to enter the trial and they learn of the trial from the doctors and nurses.
Well it's pretty obvious if a patient receives a shot then a day later they are off the ventilator that it worked.
CD12 enrollment has accelerated rapidly in just the last few weeks this is a clear sign doctors are seeing incredible results from their trial patients and are pushing to enroll even more. This combined with BB visiting the hospitals I see full enrollment in just a couple weeks if not sooner.
More likely you'll be watching it gap up out of range. Watching the price skyrocket as you're desperately trying to get an order filled. And that's if your lucky, it could be another IMMU, IMMU closed at $30 on a Friday buyout announced Saturday Monday it opened at $86
Damn grip, first you hook up with hopester now you talk about your dates from Grindr. You should stay off the computer when drinking.
Don't count on it. The next major PR could be something completely unexpected and come at anytime.
Mahboob will get an application approved.
PR announcing 75% enrollment in CD12 can come as early as this week. As of Nov 11 we only needed 33 people and with Brian Brothen out there trail blazing he filled almost 15 people in a week.
I completely agree. The strong uptrend will continue
During the webcast Nov 3 CD12 enrollment was under 250 Nov 11 enrollment is 260. Over 10 people in about a week, ( exactly how far under 250? Could be closer to 15 people). If this rate keeps up with every site Brian Brothen visits, the prior sites will most likely continue enrollment at an even faster pace now that they have been "jump started". CD12 can be at the 75% (293) in less than a couple weeks at that rate.
Looks like the falling knife landed in the head of the shorts.
So question of the day. Which CYDY major catalyst will hit first? I personally think it will come out of nowhere, something unsuspecting like major news from the cancer trial. What ever hits first the rest will follow like a stampede.
Operation Warp Speed will handle distribution. Not only handle it but will fund the entire operation. So the 2 billion dollars in Leronlimab that is ready to go will be all profit. It's a good time to be a CYDY share holder.
A little voice is telling me we will see an after hours PR today.
"Chiral Pharma is excited for the opportunity to bring leronlimab (PRO 140) to the Philippines, given its promising results against Covid-19"
Which PR will hit first Philippines approval, full enrollment CD12, news from Canada. Could see after hours PR tomorrow.
DON'T BLINK
https://www.manilatimes.net/2020/11/07/public-square/chiral-pharma-cytodyn-inc-partners-to-secure-covid-19-drug-fda-approval/792358/
"CYDY is easily the most exciting stock in small caps that is currently in beast mode"
DON'T BLINK
https://microcapdaily.com/comeback-time-for-cytodyn-inc-otcmktscydy-np-talks-blm-for-the-usa-uk-and-canada/128559/
"We are well-positioned to supply $2 billion worth of leronlimab to treat COVID-19" don't blink
https://www.globenewswire.com/news-release/2020/11/11/2124552/0/en/CytoDyn-Completes-Second-Non-dilutive-28-5-Million-Convertible-Note-Financing-with-Conversion-Rate-at-10-00-Per-Share-Without-Warrants-to-Help-Expedite-License-Applications-Here-an.html
I wouldn't doubt it, Lilly and the FDA working together, but it won't take long for Leronlimab to put Bamlanivimab out of business. It's a no brainier be admitted to a hospital for an infusion, or a shot in the doctors office. I'm sure insurance will rather pay for the shot.
Who is "others"?!! That blog you posted is so embarrassing the author won't put a name on it.